港通医疗
(301515)
| 流通市值：13.60亿 | | | 总市值：21.57亿 |
| 流通股本：6304.16万 | | | 总股本：1.00亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 265,246,991.85 | 24,286,732.74 | 754,058,316.42 | 492,343,391.1 |
| 营业收入 | 265,246,991.85 | 24,286,732.74 | 754,058,316.42 | 492,343,391.1 |
| 二、营业总成本 | 258,173,556.45 | 33,730,745.31 | 701,180,141.37 | 465,870,677.19 |
| 营业成本 | 206,648,422.61 | 15,507,795.01 | 604,228,113.76 | 393,756,754.41 |
| 税金及附加 | 2,683,194.45 | 882,604.66 | 5,201,822.9 | 3,012,045.35 |
| 销售费用 | 20,990,861.34 | 7,380,721.28 | 39,985,388.19 | 36,511,363.41 |
| 管理费用 | 17,660,531.42 | 6,194,321.4 | 31,796,379.32 | 21,863,945.08 |
| 研发费用 | 9,908,545.53 | 4,280,463.49 | 24,245,229.96 | 15,071,489.98 |
| 财务费用 | 282,001.1 | -515,160.53 | -4,276,792.76 | -4,344,921.04 |
| 其中:利息费用 | 3,103,833.89 | 1,605,605.99 | 6,314,008.83 | 4,400,271.22 |
| 其中:利息收入 | 3,201,679.11 | 2,162,019.44 | 11,244,971.62 | 9,214,293.41 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 511,856.85 | - | 957,316.41 | - |
| 加:投资收益 | -46,749.16 | - | - | - |
| 资产处置收益 | 114,157.19 | - | 75,411.84 | 31,789.3 |
| 资产减值损失(新) | -1,525,575.51 | -120,228.6 | -643,638.58 | 180,456.75 |
| 信用减值损失(新) | -19,743,183.35 | 10,872,919.37 | -47,778,144.26 | -7,876,300.95 |
| 其他收益 | 1,340,034.61 | 230,194.1 | 7,843,434.68 | 2,784,840.93 |
| 四、营业利润 | -12,276,023.97 | 1,538,872.3 | 13,332,555.14 | 21,593,499.94 |
| 加:营业外收入 | 347,786.33 | 18,237.59 | 2,066,516.09 | 720,644.53 |
| 减:营业外支出 | 111,641.17 | 52,437.67 | 298,270.94 | 116,388.09 |
| 五、利润总额 | -12,039,878.81 | 1,504,672.22 | 15,100,800.29 | 22,197,756.38 |
| 减:所得税费用 | -2,898,420.2 | -74,280.4 | 678,933.85 | 2,151,451.69 |
| 六、净利润 | -9,141,458.61 | 1,578,952.62 | 14,421,866.44 | 20,046,304.69 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -9,141,458.61 | 1,578,952.62 | 14,421,866.44 | 20,046,304.69 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -8,404,410.35 | 1,578,952.62 | 14,421,866.44 | 20,046,304.69 |
| 少数股东损益 | -737,048.26 | - | - | - |
| 扣除非经常损益后的净利润 | -10,269,336.53 | 1,414,324.12 | 5,008,448.99 | 16,746,156.5 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.09 | 0.02 | 0.15 | 0.2 |
| (二)稀释每股收益 | -0.09 | 0.02 | 0.15 | 0.2 |
| 八、其他综合收益 | -114,944.65 | - | -127,348.69 | -127,650.4 |
| 归属于母公司股东的其他综合收益 | -114,944.65 | - | -127,348.69 | -127,650.4 |
| 九、综合收益总额 | -9,256,403.26 | 1,578,952.62 | 14,294,517.75 | 19,918,654.29 |
| 归属于母公司股东的综合收益总额 | -8,519,355 | 1,578,952.62 | 14,294,517.75 | 19,918,654.29 |
| 归属于少数股东的综合收益总额 | -737,048.26 | - | - | - |
| 公告日期 | 2025-08-29 | 2025-04-21 | 2025-04-21 | 2024-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |